Jamie Love thinks he has Big Pharma in zugzwang. (That's a chess term referring to a position where one player is reduced to utter helplessness -- but must continue to play even though every additional move makes his position worse.)
Here’s what he has to say this week in Fortune Magazine about his plan to replace pharmaceutical patents with “prizes†…
"It's either going to be price controls or prizes.â€
Not so. And even though he's King of the Big Lie -- say it enough times and maybe people will begin to think it’s true -- it just isn't so. There are many alternatives that are, well, sane ones.
But as the article (authored by John Simons) concludes …
“Clearly, if industry wants to avoid this (Jamie Love's) scenario, they had better start fashioning some new ideas of their own.â€
How about a more robust discussion of a patient-centric Critical Path program for Comparative Effectiveness?
Here’s the rest of the story from Fortune:
http://money.cnn.com/2007/11/28/magazines/fortune/simons_patent.fortune/index.htm
Next up on this front is just how far Senator Bernie Sanders' Prizes vs. Patents bill gets in the Senate.
Here’s what he has to say this week in Fortune Magazine about his plan to replace pharmaceutical patents with “prizes†…
"It's either going to be price controls or prizes.â€
Not so. And even though he's King of the Big Lie -- say it enough times and maybe people will begin to think it’s true -- it just isn't so. There are many alternatives that are, well, sane ones.
But as the article (authored by John Simons) concludes …
“Clearly, if industry wants to avoid this (Jamie Love's) scenario, they had better start fashioning some new ideas of their own.â€
How about a more robust discussion of a patient-centric Critical Path program for Comparative Effectiveness?
Here’s the rest of the story from Fortune:
http://money.cnn.com/2007/11/28/magazines/fortune/simons_patent.fortune/index.htm
Next up on this front is just how far Senator Bernie Sanders' Prizes vs. Patents bill gets in the Senate.
